Cressey & Company

Investment decisions are led by Co-Founders Bryan Cressey and Peter Ehrich, alongside Partner Scott Moore. The firm maintains a flat partnership structure where senior deal leads sit on each portfolio company board. Bryan Cressey has been investing in the healthcare services sector since co-founding GTCR's healthcare practice in the 1980s.

Cressey focuses on growth equity and buyout transactions in middle-market healthcare services companies, typically targeting businesses with between $5 million and $25 million of EBITDA. The firm does not pursue early-stage venture or distressed turnarounds. Its capital is deployed primarily through control-oriented equity investments.

The firm relies on long-standing relationships with healthcare founders, executives, and industry intermediaries cultivated over Bryan Cressey's multi-decade career in the sector. Its Nashville office provides proximity to a dense cluster of healthcare services company headquarters. The operating advisor network — composed of former C-suite healthcare executives — also generates proprietary referrals.

Cressey & Company is a traditional private equity firm that manages blind-pool committed capital from institutional limited partners, not a family office. Its fund structure follows the conventional GP/LP model with a management fee and carried interest. The firm last closed a flagship fund, Fund VI, in 2018.

Cressey does not invest in biotech, pharmaceuticals, medical devices, or acute-care hospital systems. Its focus is strictly on healthcare services — specifically provider services, payer services, and healthcare IT — with an emphasis on multi-site, asset-light models where operational improvement and scale consolidation drive returns.

Bryan Cressey co-founded GTCR Golder Rauner's healthcare practice in the 1980s and built it into one of the most active healthcare private equity platforms before departing in 2008. He then formed Cressey & Company with Peter Ehrich, who had also been a partner at GTCR focused on healthcare. The two firms are separately managed and not structurally affiliated.

Cressey has historically operated as a lead or control investor rather than a passive co-investor alongside other general partners. The firm's operational playbook requires board-level influence, which makes minority, non-control co-investment positions less aligned with its strategy. Specific co-investment rights for limited partners have not been publicly detailed.